Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diet and drug combo aim to tame tumor side effects

NCT ID NCT05300048

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times

Summary

This study tested a drug called serabelisib combined with a diet that lowers insulin levels, with or without another chemotherapy drug, in people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The goal was to see if the diet could reduce side effects and improve how well the drug works. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Baptist Hospitals of Southeast Texas

    Beaumont, Texas, 77701, United States

  • Community Health Network, Inc.

    Indianapolis, Indiana, 46250, United States

  • East Carolina University

    Greenville, North Carolina, 27858, United States

  • Englewood Health

    Englewood, New Jersey, 07631, United States

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, 92663, United States

  • Lumi Research

    Kingwood, Texas, 77339, United States

  • Mayo Clinic - Rochester

    Rochester, Minnesota, 55902, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • New Jersey Cancer Care, PA

    Belleville, New Jersey, 07109, United States

  • Northwell Health

    Lake Success, New York, 11042, United States

  • Oncology Consultants, PA

    Houston, Texas, 77030, United States

  • Pacific Cancer Specialists

    Anaheim, California, 92801, United States

  • University of Alabama

    Birmingham, Alabama, 35429, United States

  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, 19104, United States

  • Valkyrie Clinical Trials

    Los Angeles, California, 90067, United States

Conditions

Explore the condition pages connected to this study.